nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinacalcet—CYP3A4—Thiotepa—urinary bladder cancer	0.106	0.347	CbGbCtD
Cinacalcet—CYP1A2—Fluorouracil—urinary bladder cancer	0.0654	0.215	CbGbCtD
Cinacalcet—CYP1A2—Etoposide—urinary bladder cancer	0.0546	0.179	CbGbCtD
Cinacalcet—CYP2D6—Doxorubicin—urinary bladder cancer	0.0307	0.101	CbGbCtD
Cinacalcet—CYP3A4—Etoposide—urinary bladder cancer	0.0286	0.094	CbGbCtD
Cinacalcet—CYP3A4—Doxorubicin—urinary bladder cancer	0.0195	0.0641	CbGbCtD
Cinacalcet—CASR—renal system—urinary bladder cancer	0.0111	0.373	CbGeAlD
Cinacalcet—CASR—E-cadherin signaling in keratinocytes—CDH1—urinary bladder cancer	0.00852	0.053	CbGpPWpGaD
Cinacalcet—CYP2D6—Codeine and Morphine Metabolism—UGT2B7—urinary bladder cancer	0.00822	0.0512	CbGpPWpGaD
Cinacalcet—CASR—E-cadherin signaling in keratinocytes—RHOA—urinary bladder cancer	0.00777	0.0483	CbGpPWpGaD
Cinacalcet—CASR—E-cadherin signaling in keratinocytes—SRC—urinary bladder cancer	0.00568	0.0354	CbGpPWpGaD
Cinacalcet—CYP1A2—urine—urinary bladder cancer	0.00562	0.189	CbGeAlD
Cinacalcet—CYP3A4—Codeine and Morphine Metabolism—UGT2B7—urinary bladder cancer	0.00537	0.0335	CbGpPWpGaD
Cinacalcet—CYP2D6—Miscellaneous substrates—CYP4B1—urinary bladder cancer	0.00535	0.0333	CbGpPWpGaD
Cinacalcet—CYP1A2—Arylamine metabolism—NAT2—urinary bladder cancer	0.00525	0.0327	CbGpPWpGaD
Cinacalcet—CASR—E-cadherin signaling in keratinocytes—EGFR—urinary bladder cancer	0.00498	0.031	CbGpPWpGaD
Cinacalcet—CYP2D6—Fatty acids—CYP4B1—urinary bladder cancer	0.00448	0.0279	CbGpPWpGaD
Cinacalcet—CYP3A4—urine—urinary bladder cancer	0.00407	0.137	CbGeAlD
Cinacalcet—CYP2D6—urine—urinary bladder cancer	0.00401	0.135	CbGeAlD
Cinacalcet—CYP2D6—Tamoxifen metabolism—UGT2B7—urinary bladder cancer	0.0038	0.0236	CbGpPWpGaD
Cinacalcet—CYP1A2—Estrogen metabolism—UGT2B7—urinary bladder cancer	0.00364	0.0227	CbGpPWpGaD
Cinacalcet—CYP1A2—Tamoxifen metabolism—UGT2B7—urinary bladder cancer	0.00322	0.02	CbGpPWpGaD
Cinacalcet—CYP2D6—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.00308	0.0192	CbGpPWpGaD
Cinacalcet—CYP3A4—Estrogen metabolism—UGT2B7—urinary bladder cancer	0.00281	0.0175	CbGpPWpGaD
Cinacalcet—CYP1A2—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.00261	0.0162	CbGpPWpGaD
Cinacalcet—CYP3A4—Tamoxifen metabolism—UGT2B7—urinary bladder cancer	0.00248	0.0155	CbGpPWpGaD
Cinacalcet—CYP1A2—Aflatoxin B1 metabolism—GSTM1—urinary bladder cancer	0.00229	0.0143	CbGpPWpGaD
Cinacalcet—CYP3A4—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.00201	0.0125	CbGpPWpGaD
Cinacalcet—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.00197	0.0123	CbGpPWpGaD
Cinacalcet—CYP3A4—Aflatoxin B1 metabolism—GSTM1—urinary bladder cancer	0.00177	0.011	CbGpPWpGaD
Cinacalcet—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.00152	0.00946	CbGpPWpGaD
Cinacalcet—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.00148	0.00919	CbGpPWpGaD
Cinacalcet—CYP2D6—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.00146	0.00907	CbGpPWpGaD
Cinacalcet—CYP1A2—Arachidonic acid metabolism—CYP4B1—urinary bladder cancer	0.00145	0.00901	CbGpPWpGaD
Cinacalcet—CYP1A2—Estrogen metabolism—NQO1—urinary bladder cancer	0.0014	0.00875	CbGpPWpGaD
Cinacalcet—CYP1A2—renal system—urinary bladder cancer	0.00138	0.0463	CbGeAlD
Cinacalcet—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.00125	0.00779	CbGpPWpGaD
Cinacalcet—CYP1A2—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.00123	0.00768	CbGpPWpGaD
Cinacalcet—CYP2D6—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.0012	0.00745	CbGpPWpGaD
Cinacalcet—CYP1A2—Phase II conjugation—GSTZ1—urinary bladder cancer	0.00118	0.00734	CbGpPWpGaD
Cinacalcet—CYP1A2—Phase II conjugation—GSTO2—urinary bladder cancer	0.00112	0.00696	CbGpPWpGaD
Cinacalcet—CYP1A2—Phase II conjugation—NAT1—urinary bladder cancer	0.00112	0.00696	CbGpPWpGaD
Cinacalcet—Paraesthesia—Thiotepa—urinary bladder cancer	0.00111	0.00221	CcSEcCtD
Cinacalcet—Hypertension—Gemcitabine—urinary bladder cancer	0.0011	0.00219	CcSEcCtD
Cinacalcet—Anaemia—Cisplatin—urinary bladder cancer	0.0011	0.00218	CcSEcCtD
Cinacalcet—CYP1A2—Estrogen Receptor Pathway—ESR1—urinary bladder cancer	0.0011	0.00683	CbGpPWpGaD
Cinacalcet—Dyspepsia—Thiotepa—urinary bladder cancer	0.00109	0.00216	CcSEcCtD
Cinacalcet—Convulsion—Fluorouracil—urinary bladder cancer	0.00109	0.00216	CcSEcCtD
Cinacalcet—Myalgia—Gemcitabine—urinary bladder cancer	0.00109	0.00216	CcSEcCtD
Cinacalcet—Chest pain—Gemcitabine—urinary bladder cancer	0.00109	0.00216	CcSEcCtD
Cinacalcet—Arthralgia—Gemcitabine—urinary bladder cancer	0.00109	0.00216	CcSEcCtD
Cinacalcet—CYP3A4—Estrogen metabolism—NQO1—urinary bladder cancer	0.00108	0.00675	CbGpPWpGaD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.00108	0.00214	CcSEcCtD
Cinacalcet—CYP1A2—Estrogen metabolism—GSTM1—urinary bladder cancer	0.00108	0.0067	CbGpPWpGaD
Cinacalcet—Decreased appetite—Thiotepa—urinary bladder cancer	0.00108	0.00214	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.00107	0.00212	CcSEcCtD
Cinacalcet—Myalgia—Fluorouracil—urinary bladder cancer	0.00107	0.00212	CcSEcCtD
Cinacalcet—Chest pain—Fluorouracil—urinary bladder cancer	0.00107	0.00212	CcSEcCtD
Cinacalcet—Fatigue—Thiotepa—urinary bladder cancer	0.00107	0.00212	CcSEcCtD
Cinacalcet—Constipation—Thiotepa—urinary bladder cancer	0.00106	0.0021	CcSEcCtD
Cinacalcet—Muscle spasms—Etoposide—urinary bladder cancer	0.00105	0.00208	CcSEcCtD
Cinacalcet—Cardiac failure—Epirubicin—urinary bladder cancer	0.00104	0.00206	CcSEcCtD
Cinacalcet—Infection—Gemcitabine—urinary bladder cancer	0.00103	0.00205	CcSEcCtD
Cinacalcet—Convulsion—Cisplatin—urinary bladder cancer	0.00103	0.00204	CcSEcCtD
Cinacalcet—CYP1A2—Phase II conjugation—UGT2B7—urinary bladder cancer	0.00102	0.00637	CbGpPWpGaD
Cinacalcet—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.00102	0.00203	CcSEcCtD
Cinacalcet—Infection—Fluorouracil—urinary bladder cancer	0.00102	0.00202	CcSEcCtD
Cinacalcet—Gastrointestinal haemorrhage—Epirubicin—urinary bladder cancer	0.00101	0.00201	CcSEcCtD
Cinacalcet—Pain in extremity—Epirubicin—urinary bladder cancer	0.00101	0.00201	CcSEcCtD
Cinacalcet—CYP1A2—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.00101	0.00631	CbGpPWpGaD
Cinacalcet—Myalgia—Cisplatin—urinary bladder cancer	0.00101	0.00201	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00101	0.00201	CcSEcCtD
Cinacalcet—Skin disorder—Gemcitabine—urinary bladder cancer	0.00101	0.00201	CcSEcCtD
Cinacalcet—Anaemia—Etoposide—urinary bladder cancer	0.00101	0.002	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.00101	0.002	CcSEcCtD
Cinacalcet—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.001	0.00199	CcSEcCtD
Cinacalcet—CYP3A4—renal system—urinary bladder cancer	0.000996	0.0335	CbGeAlD
Cinacalcet—Anorexia—Gemcitabine—urinary bladder cancer	0.000993	0.00197	CcSEcCtD
Cinacalcet—CASR—G alpha (i) signalling events—CXCL8—urinary bladder cancer	0.000987	0.00615	CbGpPWpGaD
Cinacalcet—Urticaria—Thiotepa—urinary bladder cancer	0.000984	0.00195	CcSEcCtD
Cinacalcet—CYP2D6—renal system—urinary bladder cancer	0.00098	0.033	CbGeAlD
Cinacalcet—Abdominal pain—Thiotepa—urinary bladder cancer	0.000979	0.00194	CcSEcCtD
Cinacalcet—Body temperature increased—Thiotepa—urinary bladder cancer	0.000979	0.00194	CcSEcCtD
Cinacalcet—Anorexia—Fluorouracil—urinary bladder cancer	0.000976	0.00194	CcSEcCtD
Cinacalcet—Hypotension—Gemcitabine—urinary bladder cancer	0.000973	0.00193	CcSEcCtD
Cinacalcet—Floctafenine—PTGS2—urinary bladder cancer	0.000966	1	CrCbGaD
Cinacalcet—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.000965	0.00601	CbGpPWpGaD
Cinacalcet—Infection—Cisplatin—urinary bladder cancer	0.000965	0.00191	CcSEcCtD
Cinacalcet—Cardiac failure—Doxorubicin—urinary bladder cancer	0.000962	0.00191	CcSEcCtD
Cinacalcet—Hypotension—Fluorouracil—urinary bladder cancer	0.000957	0.0019	CcSEcCtD
Cinacalcet—CYP3A4—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000953	0.00593	CbGpPWpGaD
Cinacalcet—Nervous system disorder—Cisplatin—urinary bladder cancer	0.000952	0.00189	CcSEcCtD
Cinacalcet—Cough—Etoposide—urinary bladder cancer	0.000951	0.00189	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.000949	0.00188	CcSEcCtD
Cinacalcet—Convulsion—Etoposide—urinary bladder cancer	0.000944	0.00187	CcSEcCtD
Cinacalcet—Dehydration—Epirubicin—urinary bladder cancer	0.000943	0.00187	CcSEcCtD
Cinacalcet—Skin disorder—Cisplatin—urinary bladder cancer	0.000943	0.00187	CcSEcCtD
Cinacalcet—Hypertension—Etoposide—urinary bladder cancer	0.000941	0.00187	CcSEcCtD
Cinacalcet—Gastrointestinal haemorrhage—Doxorubicin—urinary bladder cancer	0.000939	0.00186	CcSEcCtD
Cinacalcet—Pain in extremity—Doxorubicin—urinary bladder cancer	0.000939	0.00186	CcSEcCtD
Cinacalcet—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000935	0.00186	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000933	0.00185	CcSEcCtD
Cinacalcet—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000929	0.00184	CcSEcCtD
Cinacalcet—Chest pain—Etoposide—urinary bladder cancer	0.000928	0.00184	CcSEcCtD
Cinacalcet—Anorexia—Cisplatin—urinary bladder cancer	0.000926	0.00184	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.000922	0.00183	CcSEcCtD
Cinacalcet—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00092	0.00182	CcSEcCtD
Cinacalcet—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000913	0.00181	CcSEcCtD
Cinacalcet—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000912	0.00181	CcSEcCtD
Cinacalcet—Hypotension—Cisplatin—urinary bladder cancer	0.000907	0.0018	CcSEcCtD
Cinacalcet—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000906	0.0018	CcSEcCtD
Cinacalcet—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000902	0.00179	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000899	0.00178	CcSEcCtD
Cinacalcet—Fatigue—Gemcitabine—urinary bladder cancer	0.000898	0.00178	CcSEcCtD
Cinacalcet—Constipation—Gemcitabine—urinary bladder cancer	0.000891	0.00177	CcSEcCtD
Cinacalcet—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00089	0.00177	CcSEcCtD
Cinacalcet—Asthenia—Thiotepa—urinary bladder cancer	0.000889	0.00176	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—HDAC4—urinary bladder cancer	0.000886	0.00551	CbGpPWpGaD
Cinacalcet—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000885	0.00175	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000884	0.00175	CcSEcCtD
Cinacalcet—Infection—Etoposide—urinary bladder cancer	0.000884	0.00175	CcSEcCtD
Cinacalcet—Pruritus—Thiotepa—urinary bladder cancer	0.000876	0.00174	CcSEcCtD
Cinacalcet—Dehydration—Doxorubicin—urinary bladder cancer	0.000873	0.00173	CcSEcCtD
Cinacalcet—Paraesthesia—Cisplatin—urinary bladder cancer	0.000872	0.00173	CcSEcCtD
Cinacalcet—Upper respiratory tract infection—Methotrexate—urinary bladder cancer	0.000871	0.00173	CcSEcCtD
Cinacalcet—Dyspnoea—Cisplatin—urinary bladder cancer	0.000866	0.00172	CcSEcCtD
Cinacalcet—Skin disorder—Etoposide—urinary bladder cancer	0.000864	0.00171	CcSEcCtD
Cinacalcet—Anorexia—Etoposide—urinary bladder cancer	0.000848	0.00168	CcSEcCtD
Cinacalcet—Diarrhoea—Thiotepa—urinary bladder cancer	0.000847	0.00168	CcSEcCtD
Cinacalcet—Decreased appetite—Cisplatin—urinary bladder cancer	0.000844	0.00167	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000838	0.00166	CcSEcCtD
Cinacalcet—Depression—Methotrexate—urinary bladder cancer	0.000833	0.00165	CcSEcCtD
Cinacalcet—Hypotension—Etoposide—urinary bladder cancer	0.000831	0.00165	CcSEcCtD
Cinacalcet—CYP3A4—Estrogen metabolism—GSTM1—urinary bladder cancer	0.000831	0.00517	CbGpPWpGaD
Cinacalcet—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000824	0.00163	CcSEcCtD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—urinary bladder cancer	0.000823	0.00512	CbGpPWpGaD
Cinacalcet—Dizziness—Thiotepa—urinary bladder cancer	0.000819	0.00162	CcSEcCtD
Cinacalcet—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	0.000815	0.00162	CcSEcCtD
Cinacalcet—CYP2D6—Biological oxidations—GSTZ1—urinary bladder cancer	0.000814	0.00507	CbGpPWpGaD
Cinacalcet—Urticaria—Fluorouracil—urinary bladder cancer	0.000814	0.00161	CcSEcCtD
Cinacalcet—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00081	0.00161	CcSEcCtD
Cinacalcet—CYP2D6—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000803	0.005	CbGpPWpGaD
Cinacalcet—Paraesthesia—Etoposide—urinary bladder cancer	0.000799	0.00158	CcSEcCtD
Cinacalcet—CYP3A4—female reproductive system—urinary bladder cancer	0.000798	0.0268	CbGeAlD
Cinacalcet—Dyspnoea—Etoposide—urinary bladder cancer	0.000793	0.00157	CcSEcCtD
Cinacalcet—Vomiting—Thiotepa—urinary bladder cancer	0.000787	0.00156	CcSEcCtD
Cinacalcet—CYP2D6—female reproductive system—urinary bladder cancer	0.000785	0.0264	CbGeAlD
Cinacalcet—CYP3A4—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000782	0.00487	CbGpPWpGaD
Cinacalcet—Rash—Thiotepa—urinary bladder cancer	0.000781	0.00155	CcSEcCtD
Cinacalcet—Dermatitis—Thiotepa—urinary bladder cancer	0.00078	0.00155	CcSEcCtD
Cinacalcet—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000779	0.00485	CbGpPWpGaD
Cinacalcet—Headache—Thiotepa—urinary bladder cancer	0.000776	0.00154	CcSEcCtD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—urinary bladder cancer	0.000775	0.00482	CbGpPWpGaD
Cinacalcet—Decreased appetite—Etoposide—urinary bladder cancer	0.000773	0.00153	CcSEcCtD
Cinacalcet—CYP2D6—Biological oxidations—GSTO2—urinary bladder cancer	0.000772	0.00481	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—NAT1—urinary bladder cancer	0.000772	0.00481	CbGpPWpGaD
Cinacalcet—CYP1A2—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.00077	0.00479	CbGpPWpGaD
Cinacalcet—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000768	0.00152	CcSEcCtD
Cinacalcet—Body temperature increased—Cisplatin—urinary bladder cancer	0.000768	0.00152	CcSEcCtD
Cinacalcet—Fatigue—Etoposide—urinary bladder cancer	0.000767	0.00152	CcSEcCtD
Cinacalcet—CYP2D6—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000761	0.00474	CbGpPWpGaD
Cinacalcet—Constipation—Etoposide—urinary bladder cancer	0.000761	0.00151	CcSEcCtD
Cinacalcet—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000755	0.0015	CcSEcCtD
Cinacalcet—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.000754	0.0015	CcSEcCtD
Cinacalcet—Asthenia—Gemcitabine—urinary bladder cancer	0.000747	0.00148	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—GLI1—urinary bladder cancer	0.000742	0.00462	CbGpPWpGaD
Cinacalcet—Pruritus—Gemcitabine—urinary bladder cancer	0.000737	0.00146	CcSEcCtD
Cinacalcet—Nausea—Thiotepa—urinary bladder cancer	0.000736	0.00146	CcSEcCtD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—urinary bladder cancer	0.000732	0.00456	CbGpPWpGaD
Cinacalcet—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000727	0.00144	CcSEcCtD
Cinacalcet—Pruritus—Fluorouracil—urinary bladder cancer	0.000725	0.00144	CcSEcCtD
Cinacalcet—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000715	0.00142	CcSEcCtD
Cinacalcet—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000713	0.00141	CcSEcCtD
Cinacalcet—Urticaria—Etoposide—urinary bladder cancer	0.000707	0.0014	CcSEcCtD
Cinacalcet—CYP2D6—Biological oxidations—UGT2B7—urinary bladder cancer	0.000706	0.0044	CbGpPWpGaD
Cinacalcet—Abdominal pain—Etoposide—urinary bladder cancer	0.000703	0.00139	CcSEcCtD
Cinacalcet—Body temperature increased—Etoposide—urinary bladder cancer	0.000703	0.00139	CcSEcCtD
Cinacalcet—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000701	0.00139	CcSEcCtD
Cinacalcet—Asthenia—Cisplatin—urinary bladder cancer	0.000697	0.00138	CcSEcCtD
Cinacalcet—CYP2D6—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000696	0.00434	CbGpPWpGaD
Cinacalcet—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000691	0.00137	CcSEcCtD
Cinacalcet—CYP1A2—Biological oxidations—GSTZ1—urinary bladder cancer	0.00069	0.00429	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.00068	0.00424	CbGpPWpGaD
Cinacalcet—Immune system disorder—Methotrexate—urinary bladder cancer	0.000677	0.00134	CcSEcCtD
Cinacalcet—Dizziness—Fluorouracil—urinary bladder cancer	0.000677	0.00134	CcSEcCtD
Cinacalcet—Diarrhoea—Cisplatin—urinary bladder cancer	0.000664	0.00132	CcSEcCtD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NQO1—urinary bladder cancer	0.000663	0.00413	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—NQO1—urinary bladder cancer	0.000663	0.00413	CbGpPWpGaD
Cinacalcet—Vomiting—Gemcitabine—urinary bladder cancer	0.000662	0.00131	CcSEcCtD
Cinacalcet—Rash—Gemcitabine—urinary bladder cancer	0.000657	0.0013	CcSEcCtD
Cinacalcet—Dermatitis—Gemcitabine—urinary bladder cancer	0.000656	0.0013	CcSEcCtD
Cinacalcet—Hypersensitivity—Etoposide—urinary bladder cancer	0.000655	0.0013	CcSEcCtD
Cinacalcet—CYP1A2—Biological oxidations—GSTO2—urinary bladder cancer	0.000654	0.00407	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—NAT1—urinary bladder cancer	0.000654	0.00407	CbGpPWpGaD
Cinacalcet—Malnutrition—Methotrexate—urinary bladder cancer	0.000653	0.00129	CcSEcCtD
Cinacalcet—Headache—Gemcitabine—urinary bladder cancer	0.000653	0.00129	CcSEcCtD
Cinacalcet—Vomiting—Fluorouracil—urinary bladder cancer	0.000651	0.00129	CcSEcCtD
Cinacalcet—Rash—Fluorouracil—urinary bladder cancer	0.000646	0.00128	CcSEcCtD
Cinacalcet—Dermatitis—Fluorouracil—urinary bladder cancer	0.000645	0.00128	CcSEcCtD
Cinacalcet—CYP1A2—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000645	0.00402	CbGpPWpGaD
Cinacalcet—Headache—Fluorouracil—urinary bladder cancer	0.000642	0.00127	CcSEcCtD
Cinacalcet—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.00064	0.00127	CcSEcCtD
Cinacalcet—Asthenia—Etoposide—urinary bladder cancer	0.000638	0.00127	CcSEcCtD
Cinacalcet—CYP2D6—Biological oxidations—CYP4B1—urinary bladder cancer	0.000636	0.00396	CbGpPWpGaD
Cinacalcet—Immune system disorder—Epirubicin—urinary bladder cancer	0.000634	0.00126	CcSEcCtD
Cinacalcet—Pruritus—Etoposide—urinary bladder cancer	0.000629	0.00125	CcSEcCtD
Cinacalcet—Arrhythmia—Epirubicin—urinary bladder cancer	0.000627	0.00124	CcSEcCtD
Cinacalcet—CYP2D6—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000627	0.0039	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—urinary bladder cancer	0.000622	0.00387	CbGpPWpGaD
Cinacalcet—Nausea—Gemcitabine—urinary bladder cancer	0.000619	0.00123	CcSEcCtD
Cinacalcet—Vomiting—Cisplatin—urinary bladder cancer	0.000617	0.00122	CcSEcCtD
Cinacalcet—CYP1A2—Phase II conjugation—NAT2—urinary bladder cancer	0.000613	0.00381	CbGpPWpGaD
Cinacalcet—Rash—Cisplatin—urinary bladder cancer	0.000612	0.00121	CcSEcCtD
Cinacalcet—Dermatitis—Cisplatin—urinary bladder cancer	0.000612	0.00121	CcSEcCtD
Cinacalcet—Malnutrition—Epirubicin—urinary bladder cancer	0.000611	0.00121	CcSEcCtD
Cinacalcet—Diarrhoea—Etoposide—urinary bladder cancer	0.000609	0.00121	CcSEcCtD
Cinacalcet—Nausea—Fluorouracil—urinary bladder cancer	0.000608	0.00121	CcSEcCtD
Cinacalcet—Anaemia—Methotrexate—urinary bladder cancer	0.000603	0.0012	CcSEcCtD
Cinacalcet—CYP1A2—Biological oxidations—UGT2B7—urinary bladder cancer	0.000598	0.00372	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—CXCL8—urinary bladder cancer	0.000598	0.00372	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.00059	0.00367	CbGpPWpGaD
Cinacalcet—Dizziness—Etoposide—urinary bladder cancer	0.000588	0.00117	CcSEcCtD
Cinacalcet—Muscle spasms—Epirubicin—urinary bladder cancer	0.000587	0.00117	CcSEcCtD
Cinacalcet—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000587	0.00116	CcSEcCtD
Cinacalcet—Arrhythmia—Doxorubicin—urinary bladder cancer	0.00058	0.00115	CcSEcCtD
Cinacalcet—Nausea—Cisplatin—urinary bladder cancer	0.000577	0.00114	CcSEcCtD
Cinacalcet—Cough—Methotrexate—urinary bladder cancer	0.00057	0.00113	CcSEcCtD
Cinacalcet—Convulsion—Methotrexate—urinary bladder cancer	0.000566	0.00112	CcSEcCtD
Cinacalcet—Vomiting—Etoposide—urinary bladder cancer	0.000566	0.00112	CcSEcCtD
Cinacalcet—Malnutrition—Doxorubicin—urinary bladder cancer	0.000565	0.00112	CcSEcCtD
Cinacalcet—Anaemia—Epirubicin—urinary bladder cancer	0.000565	0.00112	CcSEcCtD
Cinacalcet—Rash—Etoposide—urinary bladder cancer	0.000561	0.00111	CcSEcCtD
Cinacalcet—Dermatitis—Etoposide—urinary bladder cancer	0.00056	0.00111	CcSEcCtD
Cinacalcet—Headache—Etoposide—urinary bladder cancer	0.000557	0.00111	CcSEcCtD
Cinacalcet—Arthralgia—Methotrexate—urinary bladder cancer	0.000556	0.0011	CcSEcCtD
Cinacalcet—Chest pain—Methotrexate—urinary bladder cancer	0.000556	0.0011	CcSEcCtD
Cinacalcet—Myalgia—Methotrexate—urinary bladder cancer	0.000556	0.0011	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000552	0.00109	CcSEcCtD
Cinacalcet—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000544	0.00108	CcSEcCtD
Cinacalcet—CYP1A2—Biological oxidations—CYP4B1—urinary bladder cancer	0.000539	0.00335	CbGpPWpGaD
Cinacalcet—Cough—Epirubicin—urinary bladder cancer	0.000533	0.00106	CcSEcCtD
Cinacalcet—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	0.000532	0.00331	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000531	0.00331	CbGpPWpGaD
Cinacalcet—Convulsion—Epirubicin—urinary bladder cancer	0.000529	0.00105	CcSEcCtD
Cinacalcet—Infection—Methotrexate—urinary bladder cancer	0.000529	0.00105	CcSEcCtD
Cinacalcet—Nausea—Etoposide—urinary bladder cancer	0.000528	0.00105	CcSEcCtD
Cinacalcet—Hypertension—Epirubicin—urinary bladder cancer	0.000527	0.00105	CcSEcCtD
Cinacalcet—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000525	0.00327	CbGpPWpGaD
Cinacalcet—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000523	0.00104	CcSEcCtD
Cinacalcet—Anaemia—Doxorubicin—urinary bladder cancer	0.000523	0.00104	CcSEcCtD
Cinacalcet—Arthralgia—Epirubicin—urinary bladder cancer	0.00052	0.00103	CcSEcCtD
Cinacalcet—Chest pain—Epirubicin—urinary bladder cancer	0.00052	0.00103	CcSEcCtD
Cinacalcet—Myalgia—Epirubicin—urinary bladder cancer	0.00052	0.00103	CcSEcCtD
Cinacalcet—Skin disorder—Methotrexate—urinary bladder cancer	0.000518	0.00103	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000517	0.00102	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—RBX1—urinary bladder cancer	0.000509	0.00317	CbGpPWpGaD
Cinacalcet—Anorexia—Methotrexate—urinary bladder cancer	0.000508	0.00101	CcSEcCtD
Cinacalcet—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.000505	0.00314	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.000505	0.00314	CbGpPWpGaD
Cinacalcet—Hypotension—Methotrexate—urinary bladder cancer	0.000498	0.000988	CcSEcCtD
Cinacalcet—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000498	0.0031	CbGpPWpGaD
Cinacalcet—Infection—Epirubicin—urinary bladder cancer	0.000495	0.000983	CcSEcCtD
Cinacalcet—Cough—Doxorubicin—urinary bladder cancer	0.000493	0.000978	CcSEcCtD
Cinacalcet—Convulsion—Doxorubicin—urinary bladder cancer	0.00049	0.000971	CcSEcCtD
Cinacalcet—CYP1A2—Phase II conjugation—HPGDS—urinary bladder cancer	0.00049	0.00305	CbGpPWpGaD
Cinacalcet—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000489	0.00097	CcSEcCtD
Cinacalcet—Hypertension—Doxorubicin—urinary bladder cancer	0.000488	0.000968	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000485	0.000963	CcSEcCtD
Cinacalcet—Skin disorder—Epirubicin—urinary bladder cancer	0.000484	0.000961	CcSEcCtD
Cinacalcet—Myalgia—Doxorubicin—urinary bladder cancer	0.000481	0.000955	CcSEcCtD
Cinacalcet—Arthralgia—Doxorubicin—urinary bladder cancer	0.000481	0.000955	CcSEcCtD
Cinacalcet—Chest pain—Doxorubicin—urinary bladder cancer	0.000481	0.000955	CcSEcCtD
Cinacalcet—Paraesthesia—Methotrexate—urinary bladder cancer	0.000478	0.000949	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—TSC1—urinary bladder cancer	0.000478	0.00298	CbGpPWpGaD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000478	0.000948	CcSEcCtD
Cinacalcet—Anorexia—Epirubicin—urinary bladder cancer	0.000475	0.000943	CcSEcCtD
Cinacalcet—Dyspnoea—Methotrexate—urinary bladder cancer	0.000475	0.000942	CcSEcCtD
Cinacalcet—CYP1A2—Phase II conjugation—GSTT1—urinary bladder cancer	0.000475	0.00296	CbGpPWpGaD
Cinacalcet—Dyspepsia—Methotrexate—urinary bladder cancer	0.000469	0.00093	CcSEcCtD
Cinacalcet—Hypotension—Epirubicin—urinary bladder cancer	0.000466	0.000924	CcSEcCtD
Cinacalcet—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000464	0.00289	CbGpPWpGaD
Cinacalcet—Decreased appetite—Methotrexate—urinary bladder cancer	0.000463	0.000919	CcSEcCtD
Cinacalcet—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.000462	0.00287	CbGpPWpGaD
Cinacalcet—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00046	0.000912	CcSEcCtD
Cinacalcet—Fatigue—Methotrexate—urinary bladder cancer	0.000459	0.000911	CcSEcCtD
Cinacalcet—Infection—Doxorubicin—urinary bladder cancer	0.000458	0.000909	CcSEcCtD
Cinacalcet—CYP1A2—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000455	0.00283	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000455	0.00283	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—JAG1—urinary bladder cancer	0.000455	0.00283	CbGpPWpGaD
Cinacalcet—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000454	0.000901	CcSEcCtD
Cinacalcet—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000452	0.000897	CcSEcCtD
Cinacalcet—Skin disorder—Doxorubicin—urinary bladder cancer	0.000448	0.000889	CcSEcCtD
Cinacalcet—Paraesthesia—Epirubicin—urinary bladder cancer	0.000448	0.000888	CcSEcCtD
Cinacalcet—Dyspnoea—Epirubicin—urinary bladder cancer	0.000445	0.000882	CcSEcCtD
Cinacalcet—Anorexia—Doxorubicin—urinary bladder cancer	0.00044	0.000872	CcSEcCtD
Cinacalcet—Dyspepsia—Epirubicin—urinary bladder cancer	0.000439	0.000871	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000436	0.000864	CcSEcCtD
Cinacalcet—Decreased appetite—Epirubicin—urinary bladder cancer	0.000433	0.00086	CcSEcCtD
Cinacalcet—Hypotension—Doxorubicin—urinary bladder cancer	0.000431	0.000855	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.00043	0.000854	CcSEcCtD
Cinacalcet—Fatigue—Epirubicin—urinary bladder cancer	0.00043	0.000853	CcSEcCtD
Cinacalcet—Constipation—Epirubicin—urinary bladder cancer	0.000426	0.000846	CcSEcCtD
Cinacalcet—Urticaria—Methotrexate—urinary bladder cancer	0.000423	0.00084	CcSEcCtD
Cinacalcet—CYP2D6—Biological oxidations—NAT2—urinary bladder cancer	0.000423	0.00263	CbGpPWpGaD
Cinacalcet—Body temperature increased—Methotrexate—urinary bladder cancer	0.000421	0.000835	CcSEcCtD
Cinacalcet—Abdominal pain—Methotrexate—urinary bladder cancer	0.000421	0.000835	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.00042	0.000834	CcSEcCtD
Cinacalcet—CYP2D6—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000417	0.0026	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.000416	0.00259	CbGpPWpGaD
Cinacalcet—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000414	0.000822	CcSEcCtD
Cinacalcet—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000411	0.000816	CcSEcCtD
Cinacalcet—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.00041	0.00255	CbGpPWpGaD
Cinacalcet—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000408	0.000809	CcSEcCtD
Cinacalcet—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000406	0.000806	CcSEcCtD
Cinacalcet—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000401	0.000795	CcSEcCtD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—urinary bladder cancer	0.000399	0.00249	CbGpPWpGaD
Cinacalcet—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000398	0.00079	CcSEcCtD
Cinacalcet—Fatigue—Doxorubicin—urinary bladder cancer	0.000398	0.000789	CcSEcCtD
Cinacalcet—Urticaria—Epirubicin—urinary bladder cancer	0.000396	0.000786	CcSEcCtD
Cinacalcet—Constipation—Doxorubicin—urinary bladder cancer	0.000395	0.000783	CcSEcCtD
Cinacalcet—Abdominal pain—Epirubicin—urinary bladder cancer	0.000394	0.000782	CcSEcCtD
Cinacalcet—Body temperature increased—Epirubicin—urinary bladder cancer	0.000394	0.000782	CcSEcCtD
Cinacalcet—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000393	0.000779	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—RHOA—urinary bladder cancer	0.000385	0.0024	CbGpPWpGaD
Cinacalcet—Asthenia—Methotrexate—urinary bladder cancer	0.000382	0.000758	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000377	0.000748	CcSEcCtD
Cinacalcet—Pruritus—Methotrexate—urinary bladder cancer	0.000377	0.000748	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—S100B—urinary bladder cancer	0.000369	0.0023	CbGpPWpGaD
Cinacalcet—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000367	0.000729	CcSEcCtD
Cinacalcet—Urticaria—Doxorubicin—urinary bladder cancer	0.000367	0.000727	CcSEcCtD
Cinacalcet—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000365	0.000723	CcSEcCtD
Cinacalcet—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000365	0.000723	CcSEcCtD
Cinacalcet—Diarrhoea—Methotrexate—urinary bladder cancer	0.000365	0.000723	CcSEcCtD
Cinacalcet—CYP1A2—Biological oxidations—NAT2—urinary bladder cancer	0.000358	0.00223	CbGpPWpGaD
Cinacalcet—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000358	0.00223	CbGpPWpGaD
Cinacalcet—Asthenia—Epirubicin—urinary bladder cancer	0.000358	0.00071	CcSEcCtD
Cinacalcet—CYP1A2—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000353	0.0022	CbGpPWpGaD
Cinacalcet—Pruritus—Epirubicin—urinary bladder cancer	0.000353	0.0007	CcSEcCtD
Cinacalcet—Dizziness—Methotrexate—urinary bladder cancer	0.000352	0.000699	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—RHOA—urinary bladder cancer	0.000349	0.00218	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.000349	0.00217	CbGpPWpGaD
Cinacalcet—Diarrhoea—Epirubicin—urinary bladder cancer	0.000341	0.000677	CcSEcCtD
Cinacalcet—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.00034	0.000674	CcSEcCtD
Cinacalcet—Vomiting—Methotrexate—urinary bladder cancer	0.000339	0.000672	CcSEcCtD
Cinacalcet—CYP2D6—Biological oxidations—HPGDS—urinary bladder cancer	0.000338	0.00211	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—CXCL8—urinary bladder cancer	0.000338	0.0021	CbGpPWpGaD
Cinacalcet—Rash—Methotrexate—urinary bladder cancer	0.000336	0.000666	CcSEcCtD
Cinacalcet—Dermatitis—Methotrexate—urinary bladder cancer	0.000336	0.000666	CcSEcCtD
Cinacalcet—Headache—Methotrexate—urinary bladder cancer	0.000334	0.000662	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—NCOR1—urinary bladder cancer	0.000331	0.00206	CbGpPWpGaD
Cinacalcet—Asthenia—Doxorubicin—urinary bladder cancer	0.000331	0.000657	CcSEcCtD
Cinacalcet—Dizziness—Epirubicin—urinary bladder cancer	0.00033	0.000654	CcSEcCtD
Cinacalcet—CYP1A2—Phase II conjugation—GSTP1—urinary bladder cancer	0.000329	0.00205	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—GSTT1—urinary bladder cancer	0.000328	0.00204	CbGpPWpGaD
Cinacalcet—Pruritus—Doxorubicin—urinary bladder cancer	0.000326	0.000647	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—IL2—urinary bladder cancer	0.000323	0.00201	CbGpPWpGaD
Cinacalcet—Vomiting—Epirubicin—urinary bladder cancer	0.000317	0.000629	CcSEcCtD
Cinacalcet—Nausea—Methotrexate—urinary bladder cancer	0.000316	0.000628	CcSEcCtD
Cinacalcet—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000316	0.000626	CcSEcCtD
Cinacalcet—Rash—Epirubicin—urinary bladder cancer	0.000314	0.000624	CcSEcCtD
Cinacalcet—Dermatitis—Epirubicin—urinary bladder cancer	0.000314	0.000623	CcSEcCtD
Cinacalcet—Headache—Epirubicin—urinary bladder cancer	0.000312	0.00062	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—CXCL8—urinary bladder cancer	0.000307	0.00191	CbGpPWpGaD
Cinacalcet—Dizziness—Doxorubicin—urinary bladder cancer	0.000305	0.000605	CcSEcCtD
Cinacalcet—CYP1A2—Phase II conjugation—GSTM1—urinary bladder cancer	0.000303	0.00188	CbGpPWpGaD
Cinacalcet—Nausea—Epirubicin—urinary bladder cancer	0.000296	0.000587	CcSEcCtD
Cinacalcet—Vomiting—Doxorubicin—urinary bladder cancer	0.000293	0.000582	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—IL2—urinary bladder cancer	0.000293	0.00183	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—TERT—urinary bladder cancer	0.000292	0.00182	CbGpPWpGaD
Cinacalcet—Rash—Doxorubicin—urinary bladder cancer	0.000291	0.000577	CcSEcCtD
Cinacalcet—Dermatitis—Doxorubicin—urinary bladder cancer	0.000291	0.000576	CcSEcCtD
Cinacalcet—Headache—Doxorubicin—urinary bladder cancer	0.000289	0.000573	CcSEcCtD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	0.000287	0.00178	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—HPGDS—urinary bladder cancer	0.000286	0.00178	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—GSTT1—urinary bladder cancer	0.000278	0.00173	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000277	0.00172	CbGpPWpGaD
Cinacalcet—Nausea—Doxorubicin—urinary bladder cancer	0.000274	0.000544	CcSEcCtD
Cinacalcet—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000273	0.0017	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—FGFR3—urinary bladder cancer	0.000268	0.00167	CbGpPWpGaD
Cinacalcet—CYP1A2—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000268	0.00167	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	0.000266	0.00165	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—ESR1—urinary bladder cancer	0.00026	0.00162	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.00025	0.00156	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.000238	0.00148	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	0.000238	0.00148	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.000232	0.00144	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	0.000232	0.00144	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CREBBP—urinary bladder cancer	0.000228	0.00142	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—GSTP1—urinary bladder cancer	0.000227	0.00142	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IGF1—urinary bladder cancer	0.000225	0.0014	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—EGFR—urinary bladder cancer	0.000224	0.0014	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000224	0.0014	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000221	0.00138	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000214	0.00133	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—KRAS—urinary bladder cancer	0.000212	0.00132	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—GSTM1—urinary bladder cancer	0.000209	0.0013	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000208	0.00129	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000207	0.00129	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—RHOA—urinary bladder cancer	0.000206	0.00129	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000206	0.00128	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	0.000203	0.00126	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000203	0.00126	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.000193	0.0012	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	0.000193	0.0012	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	0.000193	0.0012	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.000192	0.00119	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—ERBB2—urinary bladder cancer	0.000191	0.00119	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.00019	0.00118	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CXCL8—urinary bladder cancer	0.000181	0.00113	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—HRAS—urinary bladder cancer	0.00018	0.00112	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	0.000177	0.0011	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000175	0.00109	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IL2—urinary bladder cancer	0.000173	0.00108	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CCND1—urinary bladder cancer	0.000169	0.00105	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—MMP9—urinary bladder cancer	0.000164	0.00102	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CDKN1A—urinary bladder cancer	0.000163	0.00102	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	0.000163	0.00102	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PTEN—urinary bladder cancer	0.000163	0.00101	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—EP300—urinary bladder cancer	0.000155	0.000968	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—SRC—urinary bladder cancer	0.000151	0.000941	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	0.000149	0.000925	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000147	0.000913	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	0.000139	0.000867	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	0.000137	0.00085	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—MYC—urinary bladder cancer	0.000135	0.000843	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000135	0.000839	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—EGFR—urinary bladder cancer	0.000132	0.000825	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	0.000132	0.000822	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—NAT1—urinary bladder cancer	0.000132	0.000822	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—KRAS—urinary bladder cancer	0.000125	0.000779	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	0.000121	0.000752	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	0.000118	0.000734	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	0.000112	0.000696	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—NAT1—urinary bladder cancer	0.000112	0.000696	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—TP53—urinary bladder cancer	0.000111	0.000692	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.00011	0.000685	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	0.000109	0.000677	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—HRAS—urinary bladder cancer	0.000106	0.000662	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	0.000103	0.000639	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	0.000102	0.000637	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	0.0001	0.000623	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	9.21e-05	0.000573	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	9.11e-05	0.000567	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	8.7e-05	0.000541	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	8.63e-05	0.000537	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—NAT1—urinary bladder cancer	8.63e-05	0.000537	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	8.48e-05	0.000528	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—TYMP—urinary bladder cancer	8e-05	0.000498	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	7.89e-05	0.000491	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—NAT2—urinary bladder cancer	7.23e-05	0.00045	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	7.11e-05	0.000442	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	6.8e-05	0.000423	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—TYMP—urinary bladder cancer	6.78e-05	0.000422	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	6.71e-05	0.000418	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	6.54e-05	0.000407	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	6.51e-05	0.000405	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—RRM2—urinary bladder cancer	6.24e-05	0.000389	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—NAT2—urinary bladder cancer	6.13e-05	0.000381	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	5.78e-05	0.00036	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ENO2—urinary bladder cancer	5.78e-05	0.00036	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	5.61e-05	0.000349	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—RRM2—urinary bladder cancer	5.29e-05	0.000329	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—TYMP—urinary bladder cancer	5.23e-05	0.000326	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ENO2—urinary bladder cancer	4.9e-05	0.000305	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	4.9e-05	0.000305	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.87e-05	0.000303	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	4.75e-05	0.000296	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—NAT2—urinary bladder cancer	4.73e-05	0.000294	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.68e-05	0.000291	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—NQO1—urinary bladder cancer	4.66e-05	0.00029	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—RRM2—urinary bladder cancer	4.08e-05	0.000254	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—NQO1—urinary bladder cancer	3.95e-05	0.000246	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	3.89e-05	0.000242	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.83e-05	0.000239	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	3.78e-05	0.000235	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ENO2—urinary bladder cancer	3.78e-05	0.000235	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	3.67e-05	0.000228	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—TYMS—urinary bladder cancer	3.61e-05	0.000225	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	3.57e-05	0.000222	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	3.57e-05	0.000222	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GPX1—urinary bladder cancer	3.42e-05	0.000213	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	3.36e-05	0.000209	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.34e-05	0.000208	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	3.29e-05	0.000205	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.19e-05	0.000198	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	3.16e-05	0.000197	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—TYMS—urinary bladder cancer	3.06e-05	0.000191	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—NQO1—urinary bladder cancer	3.05e-05	0.00019	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	3.03e-05	0.000188	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	3.03e-05	0.000188	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GPX1—urinary bladder cancer	2.9e-05	0.00018	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	2.85e-05	0.000177	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	2.67e-05	0.000167	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PPARG—urinary bladder cancer	2.56e-05	0.000159	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	2.54e-05	0.000158	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	2.46e-05	0.000153	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—TYMS—urinary bladder cancer	2.36e-05	0.000147	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	2.34e-05	0.000145	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	2.34e-05	0.000145	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GPX1—urinary bladder cancer	2.24e-05	0.000139	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	2.2e-05	0.000137	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PPARG—urinary bladder cancer	2.17e-05	0.000135	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	2.08e-05	0.00013	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	2.06e-05	0.000129	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	2.01e-05	0.000125	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PTEN—urinary bladder cancer	1.76e-05	0.000109	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	1.71e-05	0.000106	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—EP300—urinary bladder cancer	1.68e-05	0.000104	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.67e-05	0.000104	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.61e-05	0.0001	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PTEN—urinary bladder cancer	1.49e-05	9.26e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—EP300—urinary bladder cancer	1.42e-05	8.83e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	1.32e-05	8.2e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PTEN—urinary bladder cancer	1.15e-05	7.15e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—EP300—urinary bladder cancer	1.1e-05	6.82e-05	CbGpPWpGaD
